Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC TiUltra WP 5.5x11.5mm: medical device reports filed with FDA

927 reports name it, 2020–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

927
device reports naming the brand
0% of all MAUDE reports · about 166 a year
180
reports, 12 months to August 2026
196 in the 12 months before
2.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 927 reports that name the brand "NobelParallel CC TiUltra WP 5.5x11.5mm" (endosseous dental implant), received between December 2020 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

180 reports arrived in the 12 months to August 2026, close to the 196 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (97.7%) and malfunction (2.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (66.2%), loss of osseointegration (12.7%) and osseointegration problem (10.6%). The patient problems coded most often are failure of implant, pain and abscess. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02652Sep 2021: 4Oct 2021: 10Nov 2021: 12Dec 2021: 122022Jan 2022: 12Feb 2022: 8Mar 2022: 17Apr 2022: 14May 2022: 4Jun 2022: 16Jul 2022: 10Aug 2022: 14Sep 2022: 12Oct 2022: 20Nov 2022: 8Dec 2022: 122023Jan 2023: 14Feb 2023: 16Mar 2023: 4Apr 2023: 18May 2023: 14Jun 2023: 12Jul 2023: 14Aug 2023: 8Sep 2023: 10Oct 2023: 6Nov 2023: 20Dec 2023: 82024Jan 2024: 22Feb 2024: 12Mar 2024: 14Apr 2024: 12May 2024: 38Jun 2024: 4Jul 2024: 18Aug 2024: 12Sep 2024: 10Oct 2024: 22Nov 2024: 14Dec 2024: 82025Jan 2025: 8Feb 2025: 32Mar 2025: 20Apr 2025: 2May 2025: 0Jun 2025: 4Jul 2025: 52Aug 2025: 24Sep 2025: 16Oct 2025: 22Nov 2025: 4Dec 2025: 142026Jan 2026: 4Feb 2026: 26Mar 2026: 14Apr 2026: 10May 2026: 20Jun 2026: 12Jul 2026: 24Aug 2026: 14

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0991982020: 1020202021: 11820212022: 14720222023: 14420232024: 18620242025: 19820252026: 1242026

Event type and report source

Event type, as classified on the report

Death0%0
Injury97.7%906
Malfunction2.3%21
Other0%0
Not given0%0

Who filed the report

Manufacturer report50.1%464
Voluntary report0%0
User facility report0%0
Distributor report49.9%463
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate61466.2%62.8%
Loss of osseointegration11812.7%22.4%
Osseointegration problem9810.6%7.7%
Patient device interaction problem222.4%0.3%
Insufficient device problem information80.9%0.2%
Device markings/labelling problema problem with the device markings or label60.6%0%
Fracturea broken bone60.6%1.6%
Migrationthe device moved from where it was placed60.6%0.1%
Device damaged by another device20.2%0%
Difficult to insertthe device was hard to insert20.2%0.4%
Mechanical problema mechanical problem20.2%0.1%
Premature separation20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant62267.1%
Painpain, site not specified808.6%
Abscessa collection of pus121.3%
Implant pain121.3%
Numbnessnumbness101.1%
Inflammationinflammation80.9%
Sinus perforation80.9%
Bone fracture(s)70.8%
Appropriate clinical signs, symptoms and conditions term/code not available20.2%
Foreign body in patientpart of a device left in the patient20.2%
Nerve damage20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC TiUltra WP 5.5x11.5mmProduct code DZEAll MAUDE reports
Reports9273,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury97.7%99.2%36.2%
Classified as malfunction2.3%0.8%62.3%
Filed by the manufacturer50.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC TiUltra WP 5.5x11.5mm reports

How many FDA reports name NobelParallel CC TiUltra WP 5.5x11.5mm?

927 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 180 in the latest 12 months.

What kinds of events are reported?

injury (97.7%) and malfunction (2.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (66.2%), loss of osseointegration (12.7%), osseointegration problem (10.6%), patient device interaction problem (2.4%) and insufficient device problem information (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50.1%) and distributor reports (49.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC TiUltra WP 5.5x11.5mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.